MUDr. Tomáš Doležal, Ph.D.
odborný pracovník ve výzkumu – Farmakologický ústav
korespondenční adresa:
Kamenice 753/5, 625 00 Brno
e‑mail: |
---|
Počet publikací: 17
2021
-
Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, rok: 2021, ročník: 21, vydání: 6, DOI
-
Smoking in women with chronic vaginal discomfort is not associated with decreased abundance of Lactobacillus spp. but promotes Mobiluncus and Gardnerella spp. overgrowth - secondary analysis of trial data including microbiome analysis
ČESKÁ GYNEKOLOGIE, rok: 2021, ročník: 86, vydání: 1, DOI
2020
-
Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients
Cancers, rok: 2020, ročník: 12, vydání: 4, DOI
-
Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry
Expert Opinion on Biological Therapy, rok: 2020, ročník: 20, vydání: 2, DOI
2019
-
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
MULTIPLE SCLEROSIS AND RELATED DISORDERS, rok: 2019, ročník: 35, vydání: OCT 2019, DOI
-
Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis
Value in health, rok: 2019, ročník: 22, vydání: 12, DOI
2014
-
Health-economic aspects of cystic fibrosis screening and therapy
, vydání: Vyd. 2014, rok: 2014